Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Wilson, James O. (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S418000, C548S452000, C514S359000
Reexamination Certificate
active
07115750
ABSTRACT:
A melanin-concentrating hormone antagonist which comprises a compound of the formula:wherein Ar1is a cyclic group which may have substituents;X is a spacer having a main chain of 1 to 6 atoms;Y is a bond or a spacer having a main chain of 1 to 6 atoms;Ar is a monocyclic aromatic ring which may be condensed with a 4 to 8 membered non-aromatic ring, and may have further substituents;R1and R2are independently hydrogen atom or a hydrocarbon group which may have substituents; R1and R2, together with the adjacent nitrogen atom, may form a nitrogen-containing hetero ring which may have substituents; R2may form a spiro ring together with Ar; or R2, together with the adjacent nitrogen atom and Y, may form a nitrogen-containing hetero ring which may have substituents; or a salt thereof;which is useful as an agent for preventing or treating obesity, etc.
REFERENCES:
patent: 6197798 (2001-03-01), Fink et al.
patent: DE 2108185 (1972-09-01), None
patent: DE 2448257 (1976-04-01), None
patent: DE 2502588 (1976-07-01), None
patent: 0533266 (1993-03-01), None
patent: 0920864 (1999-06-01), None
patent: WO 95/32967 (1995-12-01), None
patent: WO 96/35671 (1996-11-01), None
patent: WO 98/15274 (1998-04-01), None
patent: WO 98/38156 (1998-09-01), None
patent: WO 99/01127 (1999-01-01), None
patent: WP 99/52857 (1999-10-01), None
CAS printout of Perregaard et al. Chem. Abs. 124:232261, 1995.
CAS printout of Werbel et al. Chem. Abs. 73:109549, 1995.
Mewshaw, et al. “New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D7Agonist Pharmacophore. Structure—Activity Relationships of a Series of 2-(Aminomethyl)chromans” Journal of Medicinal Chemistry 40:4235-56 (1997).
Birch, et al. “N-Substituted (2,3-Dihydro-1,4-benzodioxin-2-yI)methylamine Derivatives as D1Antagonists/5-HT1APartial Agonists with Potential as Atypical Antitipsychotic Agents” Journal of Medicinal Chemistry 42-3342-55(1999).
Qu, et al. “A role for melanin-concentrating hormone in the central regulation of feeding behaviour”. Nature 380:243-247(Mar. 21, 1996).
Beilstein Registry No. 5345411, XP-002155831, (May 4, 1993).
Ishihara Yuji
Kato Kaneyoshi
Mori Masaaki
Shimomura Yukio
Suzuki Nobuhiro
Chao Mark
Fedowitz Matthew L.
Ramesh Elaine M.
Takeda Pharmaceutical Company Limited
Wilson James O.
LandOfFree
Melanin concentrating hormone antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin concentrating hormone antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin concentrating hormone antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3639975